Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IBB vs. FBTAX: which is better?

Bottom line

IBB vs FBTAX: the short answer

IBB (iShares Biotechnology ETF) and FBTAX (Fidelity Advisor Biotechnology Fund) are quite different portfolios: only about 31% of their top holdings (by weight) are shared.

IBB is cheaper at 0.44% vs 0.94% — a difference of $50 a year per $10,000 invested.

Over five years, FBTAX returned +6.4% a year vs +2.5% for IBB (reporting dates differ).

Updated Nov 19, 2026

IBB vs FBTAX side by side

IBBFBTAX
TypeETFMutual fund
Fund familyiSharesFidelity
CategoryTechnology SectorTechnology Sector
Expense ratio0.44%0.94%
Annual cost per $10k$44$94
10-yr cost on $10k (prospectus)$555$1,663
Max front loadNone—
12b-1 fee0%0.25%
1-yr return+28.0%+31.5%
5-yr return (annualized)+2.5%+6.4%
10-yr return (annualized)+4.4%+7.7%
Best quarter+26.8%+30.3%
Worst quarter−22.9%−27.8%
Net assets (fund)$5.9B$2.2B
Number of holdings254129
Portfolio turnover27%54%
Returns as ofDec 31, 2025Sep 30, 2026

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIBBFBTAXDifference
2025+28.0%+39.6%−11.5%
2024−2.4%+5.3%−7.7%
2023+3.6%+10.7%−7.1%
2022−13.6%−8.0%−5.6%
2021+1.0%−3.6%+4.6%
2020+25.9%+32.2%−6.3%
2019+24.8%+25.7%−1.0%
2018−9.1%−3.8%−5.4%
2017+21.2%+25.8%−4.6%
2016−21.5%−23.6%+2.1%

Source: Fund prospectus bar charts

Holdings overlap

9 of IBB's top 25 holdings also appear in FBTAX's top 25.

Shared top holdings
HoldingIBBFBTAX
Vertex Pharmaceuticals, Inc.7.66%1.39%
Gilead Sciences, Inc.7.52%5.70%
Amgen, Inc.7.50%2.37%
Alnylam Pharmaceuticals, Inc.5.68%3.62%
Argenx SE3.15%3.00%
Insmed, Inc.2.95%3.05%
Natera, Inc.2.11%1.43%
Biogen, Inc.2.03%2.71%
Moderna, Inc.0.88%1.60%

Source: SEC Form N-PORT

IBB top 10

  1. BlackRock Funds III — 13.18%
  2. Vertex Pharmaceuticals, Inc. — 7.66%
  3. Gilead Sciences, Inc. — 7.52%
  4. Amgen, Inc. — 7.50%
  5. Regeneron Pharmaceuticals, Inc. — 5.70%
  6. Alnylam Pharmaceuticals, Inc. — 5.68%
  7. IQVIA Holdings, Inc. — 3.18%
  8. Argenx SE — 3.15%
  9. Insmed, Inc. — 2.95%
  10. Mettler-Toledo International, Inc. — 2.49%

FBTAX top 10

  1. Abbvie Inc — 14.71%
  2. Gilead Sciences Inc — 5.70%
  3. Spyre Therapeutics Inc — 3.83%
  4. Alnylam Pharmaceuticals Inc — 3.62%
  5. Dianthus Therapeutics Inc — 3.55%
  6. Cogent Biosciences Inc — 3.25%
  7. Oruka Therapeutics Inc — 3.24%
  8. Insmed Inc — 3.05%
  9. Revolution Medicines Inc — 3.00%
  10. Argenx Se — 3.00%

FAQ

What is the difference between IBB and FBTAX?
IBB (iShares Biotechnology ETF) and FBTAX (Fidelity Advisor Biotechnology Fund) are quite different portfolios: only about 31% of their top holdings (by weight) are shared. IBB is cheaper at 0.44% vs 0.94% — a difference of $50 a year per $10,000 invested.
Which is cheaper, IBB or FBTAX?
IBB has the lower expense ratio (0.44%).
Should I own both IBB and FBTAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.